NDC 87625-110 - SurviveX Travel Med MOD
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 87625-110
- Manufacturer
- Intent Brands LLC
- Effective date
- 2026-08-04
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| SurviveX Travel Med MOD - Intent Brands LLC | Intent Brands LLC | 2026-08-04 | HUMAN OTC DRUG LABEL |
| SurviveX Travel Med Kit - Intent Brands LLC | Intent Brands LLC | 2026-05-07 | HUMAN OTC DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Concentrated ibuprofen infants | IBUPROFEN | Guardian Drug Company | 3a32f0c7-c03e-4783-a429-08280993ddfb | 2022-11-28 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | TOPCO ASSOCIATES LLC | cef74c2f-0c23-609d-e053-2a95a90a6b8e | 2022-11-23 | Warnings | 310965 WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Care One (American Sales Company) | 016299ef-ad40-46fd-acfc-e74ffee3d9b4 | 2022-11-21 | Warnings | WK2XYI10QM |
| signature care childrens ibuprofen | IBUPROFEN | Safeway | c30fbb8f-a293-4f6e-9495-11402548fe2d | 2022-11-15 | Warnings | WK2XYI10QM |
| OSTEOBIOS | CALCITONIN HUMAN - CALCIUM CARBONATE - CALCIUM FLUORIDE - CALCIUM PHOSPHATE - ISOLEUCINE - LEUCINE - LYSINE - METHIONINE - PHENYLALANINE - SUS SCROFA BONE - SUS SCROFA PARATHYROID GLAND - THREONINE - TRYPTOPHAN - VALINE - | Guna spa | 1b8c8c83-1a46-4c0a-b883-e7dce781c5d1 | 2022-11-14 | Warnings | H0G9379FGK |
| WAL-ITIN | LORATADINE | WALGREENS | 9e155aae-4735-4aab-bda9-c21ea29529a4 | 2022-11-11 | Warnings | 7AJO3BO7QN |
| Omeprazole, Sodium bicarbonate | OMEPRAZOLE, SODIUM BICARBONATE | Guardian Drug Company | e5c6c2cf-fb3b-456a-a0a0-be396d6f8319 | 2022-11-08 | Warnings, Adverse reactions | 8MDF5V39QO |
| Ibuprofen | IBUPROFEN | Dolgencorp, Inc. (DOLLAR GENERAL & REXALL) | 7f510feb-023c-4974-af6d-3e7a30cef362 | 2022-11-07 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Dolgencorp, Inc. (DOLLAR GENERAL & REXALL) | 8de40427-1be3-4a86-bc4c-9659ebaa203f | 2022-11-07 | Warnings | WK2XYI10QM |
| Loratadine | LORATADINE | Chain Drug Consortium, LLC | 21199958-ac67-4f72-8a8c-4d7d31fa9da4 | 2022-11-04 | Warnings | 311372 7AJO3BO7QN |
| Loratadine ODT | LORATADINE | Chain Drug Consortium, LLC | 7674009d-492d-4005-a652-f12b91428c0d | 2022-11-04 | Warnings | 7AJO3BO7QN |
| Ibuprofen and Pseudoephedrine HCl | IBUPROFEN AND PSEUDOEPHEDRINE HCL | Amerisource Bergen | 8d397f4f-ac5e-426d-a26b-ee064b6e5028 | 2022-11-04 | Warnings | WK2XYI10QM |
| Loratadine | LORATADINE | McLane Company, Inc. | f988f9fb-463d-4aaa-b83d-54a3b114e570 | 2022-11-04 | Warnings | 311372 7AJO3BO7QN |
| Loratadine ODT | LORATADINE | DISCOUNT DRUG MART | b4a11eb4-cff8-4280-9dc9-757d51100354 | 2022-11-04 | Warnings | 7AJO3BO7QN |
| Loratadine ODT | LORATADINE | Ahold U.S.A., Inc, | 092aec8d-57d5-4487-8e1a-b4b586bee7cf | 2022-11-04 | Warnings | 7AJO3BO7QN |
| Loratadine ODT | LORATADINE | Wal-Mart Stores, Inc. | f399f7ab-ab51-46ff-bce9-3014eb021930 | 2022-11-04 | Warnings | 7AJO3BO7QN |
| Loratadine ODT | LORATADINE | Aurohealth LLC | 1ba8e521-0b0f-419c-b7c3-fa9586f83f36 | 2022-11-03 | Warnings | 7AJO3BO7QN |
| Loratadine ODT | LORATADINE | Aurohealth LLC | 9f44382f-c289-402d-bb98-ec5fa80fc25d | 2022-11-03 | Warnings | 7AJO3BO7QN |
| Loratadine ODT | LORATADINE | Aurohealth LLC | 8c119b12-f512-4207-b354-7244d1f9963a | 2022-11-03 | Warnings | 7AJO3BO7QN |
| Loratadine | LORATADINE | Aurohealth LLC | 839e2e03-9ebb-4a44-b753-fb174bd36115 | 2022-11-03 | Warnings | 311372 7AJO3BO7QN |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.